Document is current
Any future updates will be listed below
-
Authors
Callon, Domitille
Hovhannisyan, Yeranuhi
Friob, Gabriel
Vartanian-Grimaldi, Jean-Sébastien
Guennec, Brice-Emmanuel
Lebreil, Anne-Laure
Li, Zhenlin
Suspène, Rodolphe
Andreoletti, Laurent
Fornès, Paul
Berri, Fatma
Vartanian, Jean-Pierre
Joanne, Pierre
Agbulut, Onnik
-
Funding
Funding for this research was provided by:
Université de Reims Champagne-Ardenne
Fédération Française de Cardiologie
Sorbonne Université
AFM-Téléthon (22142)
Fonds Marion Elizabeth BRANCHER
Institut Pasteur
- License Information
-
More Information
Article History
Received: 10 August 2025
Accepted: 17 December 2025
First Online: 27 February 2026
Declarations
:
: All the iPSC lines used in this study were generated from peripheral blood mononuclear cells (PBMC). Informed consent (written by Phenocell SAS (Grasse, France)) was obtained for the use of these PBMC and their derivatives for research in an anonymized way. This project (title: hiPSC4DCM) was carried out within the framework of a ministerial ethics approval that was obtained from the French Ministry for Research, Higher Education and Innovation (Name of the institutional approval committee or unit: French Ministry for Research, Higher Education and Innovation; Approval number: AC-2019-3388; Date of approval: 29 May 2019).
: Not applicable.
: The authors declare no competing interests.
